ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Donor Dendritic Cells – Potential New Therapeutic Target in Transplantation

T. Ueno,1,2,3 M. Yeung,1 M. McGrath,1 H. Iwamoto,3 Y. Nakamura,3 O. Konnno,3 Y. Kihara,3 T. Yokoyama,3 S. Ono,3 T. Ikeda,3 S. Kawachi,3 B. Ibrahim,1 A. Chandraker.1

1Renal, Brigham and Women's Hospital, Harvard Medical School, Boston, MA
2Center for Systems Biology, Massachusetts General Hospital, Harvard Medical School, Boston, MA
3Transplant Surgery, Tokyo Medical University, Hachioji, Tokyo, Japan.

Meeting: 2015 American Transplant Congress

Abstract number: C20

Keywords: Antigen presentation, Heart, Image analysis, Mice

Session Information

Date: Monday, May 4, 2015

Session Name: Poster Session C: Antigen Presenting Cells in Alloimmune Responses/B Cells and Antibody in Alloimmune Responses

Session Time: 5:30pm-6:30pm

 Presentation Time: 5:30pm-6:30pm

Location: Exhibit Hall E

Related Abstracts
  • Potential Contributions to the Direct Pathway by Donor Dendritic Cells at Vascularized Graft
  • Modulating T Cell Migration in the Postischemic Liver: Hepatic Stellate Cells as New Therapeutic Target?

Background: It is clear that T cells play a central role in the process of allograft rejection. However, donor dendritic cells (dDC) are the most potent antigen-presenting cells and have proven to be major regulators in determining the fate of the alloimmune response. By monitoring the complex behavior of cells, it will possible to answer many of outstanding questions in the field.

Methods:

We have now adapted the use of intravital microscopy (IVM) to track EYFP DC motility, morphology, and cell density in real-time.

Results:

Since dDC located at graft are exposed to host cells right after reperfusion, our recent findings could provide us the following possibilities; 1) dDC have already been activated during ischemic time to prepare for start cross-talking with host cells right after reperfusion, and 2) dDC are the most potent antigen presenting cells, which suggest “dDC might play an emerging role as a bridge between innate immunity and alloimmunity in cardiac transplant model”.

Conclusions:

To our knowledge, this is the first observation that T cells can be primed by interactions with dDC outside of secondary lymphoid tissues following transplantation within an hour. If this is the case, dDC could be the most potent therapeutic target in cardiac transplant model.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Ueno T, Yeung M, McGrath M, Iwamoto H, Nakamura Y, Konnno O, Kihara Y, Yokoyama T, Ono S, Ikeda T, Kawachi S, Ibrahim B, Chandraker A. Donor Dendritic Cells – Potential New Therapeutic Target in Transplantation [abstract]. Am J Transplant. 2015; 15 (suppl 3). https://atcmeetingabstracts.com/abstract/donor-dendritic-cells-potential-new-therapeutic-target-in-transplantation/. Accessed January 22, 2021.

« Back to 2015 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.
    • Penis Transplantation: First U.S. Experience.
    • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
    • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
    • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
    • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

    Visit Our Partner Sites

    American Transplant Congress (ATC)

    Visit the official site for the American Transplant Congress »

    American Journal of Transplantation

    The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

    American Society of Transplantation (AST)

    An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

    American Society of Transplant Surgeons (ASTS)

    The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

    Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

    Privacy Policy

    loading Cancel
    Post was not sent - check your email addresses!
    Email check failed, please try again
    Sorry, your blog cannot share posts by email.
    This site uses cookies: Find out more.